| CAS Number | 2212020-52-3 |
| Other Names | LY-3502970, LY 3502970, LY3502970 |
| IUPAC Name | 3-[(1S,2S)-1-[5-[(4S)-2,2-dimethyloxan-4-yl]-2-[(4S)-2-(4-fluoro-3,5-dimethylphenyl)-3-[3-(4-fluoro-1-methylindazol-5-yl)-2-oxoimidazol-1-yl]-4-methyl-6,7-dihydro-4H-pyrazolo[4,3-c]pyridine-5-carbonyl]indol-1-yl]-2-methylcyclopropyl]-4H-1,2,4-oxadiazol-5-one |
| Molecular Formula | C₄₈H₄₈F₂N₁₀O₅ |
| Molecular Weight | 882.97 |
| Purity | ≥99% Pure (LC-MS) |
| Powder Availability | 30 tablets (10mg/tablet, 300mg total)
60 capsules (10mg/capsule, 600mg total) |
| Storage Condition | Store in cool dry environment, away from direct sunlight. |
| Terms | All products are for laboratory developmental research USE ONLY. Products are not for human consumption. |
New Releases Category, PEPTIDE Glps, PEPTIDE Tablets, Peptides
ORFORGLIPRON (LY-3502970) PEPTIDE POWDER (30 TABLETS) (10MG/TABLET, 300MG TOTAL)
$89.99
Orforglipron is sold for laboratory research use only. Terms of sale apply. Not for human consumption, nor medical, veterinary, or household uses. Please familiarize yourself with our prior to ordering.
| Dimensions | 2 × 2 × 3.5 in |
|---|---|
| Options | 30 Tablets (14mg/tablet), 30 Tablets (7mg/tablet) |







Reviews
There are no reviews yet.